Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Antiplatelet Therapy According to CYP2C19 Genotype in Coronary Artery Disease: A Real World Study

NCT05174143 is registered in ClinicalTrials.gov with Xinjiang Medical University as lead sponsor.

NCT NCT05174143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05174143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Antiplatelet Therapy According to CYP2C19 Genotype in Coronary Artery Disease: A Real World Study
Lead sponsor
Xinjiang Medical University
Phase
Observational
Overall status
Completed
Start date
December 31, 2016
Completion date
October 31, 2021
Enrollment
15,000 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease